| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0009-9236(95)90077-2 |
| P698 | PubMed publication ID | 7628187 |
| P2093 | author name string | X. Luo | |
| R. C. Ribeiro | |||
| M. V. Relling | |||
| P. Mathew | |||
| D. S. Sonnichsen | |||
| P2860 | cites work | American journal of hospital pharmacy | Q26839747 |
| Cancer Treatment Reports | Q27710285 | ||
| Phase I study of oral etoposide in children with refractory solid tumors | Q33491608 | ||
| 21-day schedule oral etoposide in children--a feasibility study | Q33492250 | ||
| Chronic oral etoposide | Q37619473 | ||
| The clinical pharmacology of etoposide | Q37619479 | ||
| Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer | Q41077289 | ||
| Pharmacologically based dosing of etoposide: a means of safely increasing dose intensity | Q41774519 | ||
| The effect of etoposide on human CFU-GM. | Q41928053 | ||
| The effect of dose on the bioavailability of oral etoposide. | Q42025055 | ||
| The effect of food and concurrent chemotherapy on the bioavailability of oral etoposide. | Q42228926 | ||
| Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial | Q43972876 | ||
| Etoposide pharmacokinetics in patients with normal and abnormal organ function | Q57223635 | ||
| Low-dose oral etoposide: a new role for an old drug? | Q68480285 | ||
| A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer | Q69355056 | ||
| The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observation | Q69676336 | ||
| Variable bioavailability following repeated oral doses of etoposide | Q70118152 | ||
| Pharmacokinetics of VP16-213 given by different administration methods | Q70367546 | ||
| Chronic oral etoposide in small-cell lung cancer: clinical and pharmacokinetic results | Q70472939 | ||
| Bioavailability of low-dose oral etoposide | Q70543559 | ||
| Pharmacokinetics of etoposide: correlation of pharmacokinetic parameters with clinical conditions | Q70558143 | ||
| A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicity | Q72038139 | ||
| Long-term oral etoposide in metastatic breast cancer: clinical and pharmacokinetic results | Q72559645 | ||
| Etoposide pharmacokinetics and pharmacodynamics after acute and chronic exposure to cisplatin | Q72793441 | ||
| Disposition of total and unbound etoposide following high-dose therapy | Q72814523 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| etoposide | Q418817 | ||
| pharmacodynamics | Q725307 | ||
| P304 | page(s) | 99-107 | |
| P577 | publication date | 1995-07-01 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Pharmacokinetics and pharmacodynamics of 21-day continuous oral etoposide in pediatric patients with solid tumors | |
| Pharmacokinetics and pharmacodynamics of 21-day continuous oral etoposide in pediatric patients with solid tumors* | |||
| P478 | volume | 58 |
| Q35202886 | Clinical and cellular pharmacology in relation to solid tumours of childhood |
| Q30497854 | Clinical pharmacology in the adolescent oncology patient |
| Q33813327 | Cytochrome P450 3A: ontogeny and drug disposition |
| Q44165792 | Limited and optimal sampling strategies for etoposide and etoposide catechol in children with leukemia |
| Q41440111 | Pharmacokinetic optimisation of cancer chemotherapy. Effect on outcomes |
| Q35771512 | Pharmacokinetic optimisation of treatment with oral etoposide. |
| Q34099816 | Pharmacokinetically guided administration of chemotherapeutic agents |
| Q36341632 | Population pharmacokinetic studies in pediatrics: issues in design and analysis |
| Q41139560 | The clinical pharmacology of etoposide: an update |
| Q40911128 | Therapeutic drug monitoring opportunities in cancer therapy |
Search more.